Results 81 to 90 of about 13,949 (177)

FC-duplex IgG1 (HTLV-1/2): Qualifying the flow cytometry IgG1 duplex assay for differential diagnosis of HTLV-1 and HTLV-2 infections. [PDF]

PLoS Negl Trop Dis
Martins JP, Santos FA, Bicalho KA, Coelho-Dos-Reis JGA, Peruhype-Magalhães V, Ribeiro MA, Sá RG, de Carvalho LP, Vallinoto ACR, Amaral LR, Carneiro-Proietti ABF, Teixeira-Carvalho A, Costa AG, Martins-Filho OA, Araújo MSS.   +14 more
europepmc   +1 more source

Therapeutic Approaches for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis: Current and Emerging Strategies. [PDF]

Pathogens
Nakamura T, Satoh K.
europepmc   +1 more source

Immune escape mechanisms and therapeutic advances in virus-associated hematological malignancies. [PDF]

Blood Cancer J
Li T, Wang C, Xiao Q, Zhang X, Yang Z, Li J, Liu Y.   +6 more
europepmc   +1 more source

Morbidity and Mortality Among People Living With HTLV-1: A 30-Year Retrospective Analysis in a Brazilian Cohort. [PDF]

J Med Virol
Neves ES, Espíndola OM, Oliveira RVC, Leite ACCB, Lima MASD, Silva MTT, Osellame R, Guimarães PAP, Batista RV, Oliveira ALA, Araújo AQC.   +10 more
europepmc   +1 more source

HTLV-1 genetic diversity of 52 complete sequences from 14 African countries reveals novel variants and a lack of typical P12/P8 and P30 accessory proteins in HTLV-1b, d, and f genotypes. [PDF]

Emerg Microbes Infect
Cassar O, Djuicy DD, Begliomini G, Ramassamy JL, Oloumbou EF, Mouinga-Ondeme A, Njouom R, Marcais A, Deruelle E, Hermine O, Soriano V, de Mendoza C, Taylor G, Afonso PV, Gessain A.   +14 more
europepmc   +1 more source

Design and in silico evaluation of an mRNA vaccine against HTLV-1 using AI-driven reverse vaccinology approaches. [PDF]

PLoS One
Seifi N, Nezafat N, Hajizade MS, Negahdaripour M.   +3 more
europepmc   +1 more source

Impact of oncogenic viruses on autoimmune diseases and tumorigenesis. [PDF]

Infect Agent Cancer
Hamidi Sofiani V, Khodadadpour Mahani F, Farsiu N, Yousefi M, Naderi M, Ahmadi G, Nakhaie M.   +6 more
europepmc   +1 more source

Exploitation of CREB signaling by HTLV-1 and BLV: A central axis in viral persistence and leukemogenesis. [PDF]

Med Oncol
Farjami Z, Akbarin MM.
europepmc   +1 more source

The viral and host genomic landscape of human T-cell leukemia virus type I in Peru. [PDF]

Virol J
Enriquez-Vera D, Li J, Nakazaki-Aza J, Mochida K, Suzuki Y, Gotuzzo E, Montes M, Morishita K, Nakahata S.   +8 more
europepmc   +1 more source

Editorial: HTLV-1 and EBV-related disorders: pathogenesis and clinical advances. [PDF]

Front Med (Lausanne)
Miyashiro D, Casseb J, Sugaya M, Yasui H, Sanches JA.   +4 more
europepmc   +1 more source